Discontinuation report UNIPHYL
Report ID | 133063 |
Drug Identification Number | 02014165 |
Brand name | UNIPHYL |
Common or Proper name | Uniphyl |
Company Name | ELVIUM LIFE SCIENCES |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | THEOPHYLLINE |
Strength(s) | 400MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 50 |
ATC code | R03DA |
ATC description | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2021-02-08 |
Actual discontinuation date | |
Remaining supply date | 2021-02-08 |
Discontinuation status | To be discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-02-01 | English | Compare |
v2 | 2021-02-01 | French | Compare |
Showing 1 to 2 of 2